Transgene Biotek Ltd

NSE: TRABI · BSE: 526139 · Healthcare · 20 announcements

Share price: ₹2.59
Market cap: ₹19.62 Cr
Revenue (annual): ₹0.21 Cr
Net profit (annual): ₹-1.65 Cr
P/E (TTM): -12.2×Sector 54.5×
Promoter holding: 23.64%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 1 Management Change 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

2 Nov 2026 12:08 IST BSE

Other Announcement

Transgene Biotek Other Announcement

Transgene Biotech appointed M/s. Harish Gummadi & Co as Statutory Auditor for a two-month term effective 2 November 2026. The appointment was approved at the board meeting on the same date.

Execution: 2 months

Open announcement → Read the filing ↗

Transgene Biotek Ltd by type

Other Announcement 5
Financial Results 4
Board Meeting Date 3
Management Change 3